Implantable cardiac defibrillators for patients with non-ischaemic cardiomyopathy

Simple item page
dc.contributor.authorEl Moheb, Mohamad N.
dc.contributor.authorNicolas, Johny
dc.contributor.authorIskandarani, Ghida
dc.contributor.authorAkl, Elie A.
dc.contributor.authorRefaat, Marwan M.
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:49:51Z
dc.date.available2025-01-24T11:49:51Z
dc.date.issued2017
dc.description.abstractThis is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effects of implantable cardiac defibrillators on patients with non-ischaemic cardiomyopathy compared to optimal medical therapy, and the adverse events associated with using these devices. © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
dc.identifier.doihttps://doi.org/10.1002/14651858.CD012738
dc.identifier.eid2-s2.0-85026491355
dc.identifier.urihttp://hdl.handle.net/10938/30914
dc.language.isoen
dc.publisherJohn Wiley and Sons Ltd
dc.relation.ispartofCochrane Database of Systematic Reviews
dc.sourceScopus
dc.subjectArticle
dc.subjectCardiac resynchronization therapy
dc.subjectCardiovascular mortality
dc.subjectHealth care cost
dc.subjectHospitalization
dc.subjectHuman
dc.subjectImplantable cardioverter defibrillator
dc.subjectLeft ventricular systolic dysfunction
dc.subjectMortality
dc.subjectNonischemic cardiomyopathy
dc.subjectPrimary prevention
dc.subjectPriority journal
dc.subjectQuality of life
dc.subjectRandomized controlled trial (topic)
dc.subjectSudden cardiac death
dc.subjectSystematic review
dc.titleImplantable cardiac defibrillators for patients with non-ischaemic cardiomyopathy
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2017-8806.pdf
Size:
229.02 KB
Format:
Adobe Portable Document Format
Download

Collections

Internal Medicine